MDXG - MiMedx Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
6.11
+0.10 (+1.66%)
At close: 3:57PM EST
Stock chart is not supported by your current browser
Previous Close6.01
Open6.01
Bid0.00 x 1000
Ask0.00 x 800
Day's Range5.98 - 6.28
52 Week Range0.95 - 6.28
Volume284,212
Avg. Volume182,743
Market Cap676.707M
Beta (3Y Monthly)0.71
PE Ratio (TTM)19.65
EPS (TTM)0.31
Earnings DateApr 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.00
  • Benzinga

    12 Stocks With Short Ratios Above 50

    Short interest can be an extremely helpful too for traders looking to get a feel for how a stock might react to a catalyst or gauge the overall bullish or bearish sentiment in a stock. Stocks with extremely ...

  • PR Newswire

    MiMedx Announces Resignation of Board Member

    MARIETTA, Ga., Sept. 20, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or "the Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that Luis A. Aguilar has notified the Company of his resignation from the Board of Directors. Dr. Kathleen Behrens Wilsey, Chair of the MiMedx Board of Directors, stated, "On behalf of the Board and the Company, we thank Luis for his commitment and contributions.

  • PR Newswire

    MiMedx Announces Agreement Regarding 2019 and 2020 Shareholder Meetings

    MARIETTA, Ga. , Aug. 8, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics ...

  • Business Wire

    Shareholder Group Comments on MiMedx Shareholder Meeting

    The MiMedx Shareholder Group (Petit, George, Furstenberg) wants to thank all of our shareholders that voted for our slate at the 2018 annual meeting that was held today. This means that there will probably not be a 2019 shareholder meeting held on August 19th or sooner. Also, the Board will be able to make further changes in the bylaws to further thwart shareholders exercising their rights.

  • PR Newswire

    MiMedx Shareholders Overwhelmingly Support Election of All Three of MiMedx's Highly Qualified Director Nominees

    Preliminary Vote Count Indicates that MiMedx's Director Nominees Received Support from Approximately 80% of the Votes Cast MiMedx Shareholders Reject Petit Group's Proposal to Hold 2019 Meeting in August ...

  • Business Wire

    MiMedx Continues to Fight against Holding 2019 Annual Meeting

    Hialeah Municipal Fund, a MiMedx shareholder, filed a lawsuit April 18, 2019, to force the Company to hold the 2019 Annual Meeting for the election of three Class III directors on June 17, 2019, at the same time as the Court ordered the Company to hold the 2018 Annual Meeting. Just as MiMedx did in opposing the first Hialeah lawsuit regarding the 2018 Annual Meeting for the election of three Class II directors, they are refusing to agree on a date to hold the 2019 Annual Meeting. The Company filed a Notice of Hearing for its Motion to Dismiss the second Hialeah lawsuit in the Circuit Court of Leon County, Florida on June 11, 2019.

  • Business Wire

    Former Chairman and CEO "Pete" Petit Highlights Flaws in Revenue Recognition Allegations

    All the revenue recognition allegations against MiMedx purposefully ignore the stark reality that the Company collected basically all of its booked revenue over the years. In addition, the Company bought over $130 million of its stock back without incurring debt or affecting revenue and profit growth.

  • PR Newswire

    MiMedx Urges Shareholders to Vote Today "FOR" All of the Board's Highly Qualified Nominees on the BLUE Proxy Card

    MARIETTA, Ga., June 14, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, encourages shareholders to vote "FOR" all of the Board's highly qualified nominees online or by telephone by following the easy instructions on the BLUE Proxy Card. The 2018 Annual Meeting of Shareholders (the "Annual Meeting") will be held on Monday, June 17, 2019 – shareholders are urged to vote the BLUE proxy card TODAY.

  • PR Newswire

    MiMedx Highlights Skills and Experience of Director Nominees

    Company Urges Shareholders to Vote with the BLUE Card Online or By Phone Today MARIETTA, Ga. , June 13, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), ...

  • Business Wire

    Mimedx Shareholder Group Calls out Significant Drop in Mimedx’s Profitability since the Original CEO & COO Were Asked to Leave the Company on June 30th, 2018

    MiMedx Group, Inc. just announced the signing of an agreement for a $75 million line of credit. The documents that the Company had to publish included for the first time its earnings before interest, taxes, depreciation and amortization (EBITDA) since the second quarter of 2018. In the Company’s disclosure, the EBITDA for the second quarter of 2018 was $24.8 million.

  • PR Newswire

    Leading Independent Proxy Advisory Firm Glass Lewis Joins ISS and Egan-Jones in Recommending MiMedx Shareholders Vote "For" All Three of the Company's Director Nominees

    MARIETTA, Ga., June 12, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that leading independent proxy advisory firm Glass, Lewis & Co. ("Glass Lewis") has joined Institutional Shareholder Services ("ISS") and Egan-Jones Proxy Services ("Egan-Jones") in recommending MiMedx shareholders vote "FOR" the Company's three director nominees – K. Todd Newton, Dr. Kathleen Behrens Wilsey and Timothy R. Wright – on the BLUE proxy card in connection with the Company's 2018 Annual Meeting of Shareholders to be held on June 17, 2019.

  • PR Newswire

    MiMedx Secures $75 million Non-Dilutive Debt Financing

    Completes Key Milestone in Execution of Company's Long-Range Strategic Plan MARIETTA, Ga. , June 11, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), ...

  • PR Newswire

    Leading Independent Proxy Advisory Firms ISS and Egan-Jones Recommend That MiMedx Shareholders Vote the BLUE Card "FOR" All Three of the Company's Director Nominees

    ISS Recommends Shareholders Vote "AGAINST" the Petit Group's Shareholder Proposals ISS Recommends Shareholders Do Not Vote the White Card MARIETTA, Ga. , June 11, 2019 /PRNewswire/ -- MiMedx ...

  • Business Wire

    Mimedx Shareholder Group Urges Shareholders to Vote on the White Proxy Card for the 2018 Annual Meeting of Mimedx Group, Inc. on June 17, 2019

    IT IS ONLY BY A COMBINATION OF THESE TWO OVERDUE BOARD ELECTIONS THAT YOU, THE SHAREHOLDER, WILL HAVE THE RIGHT TO VOTE ON THE MAJORITY OF THE BOARD OF YOUR COMPANY. We TRUST YOU to know the Company DID NOT WANT YOU TO HAVE THIS RIGHT TO CHANGE CONTROL NOW. Whether by their actions in the Courts in Florida, or by delaying for at least six months a request of the SEC to grant an exemption to hold the 2018 meeting, the Company has done and continues to do everything in its power to DELAY AND DENY YOU THIS RIGHT.

  • PR Newswire

    MiMedx Issues Additional Information to Shareholders

    MARIETTA, Ga., June 10, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today issued additional information to shareholders regarding the Company's upcoming 2018 annual meeting of shareholders (the "Annual Meeting"), scheduled to be held on June 17, 2019 at 9:00 a.m. local time, at the Marietta Conference Center (Hilton Atlanta/Marietta) at 500 Powder Springs St., Marietta, GA 30064.

  • PR Newswire

    MiMedx Urges Shareholders to Vote "FOR" All of the Board's Qualified Nominees on the BLUE Proxy Card

    MARIETTA, Ga., June 7, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, is sending a new mailing to shareholders highlighting the experience of its three new highly qualified nominees standing for election to the Board of Directors (the "Board") at the 2018 annual meeting of shareholders scheduled for June 17, 2019, and calling on shareholders to vote the Company's BLUE proxy card.

  • PR Newswire

    MiMedx Issues New Presentation for Investors in Advance of 2018 Annual Meeting

    MARIETTA, Ga., June 5, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today released an investor presentation summarizing the reasons why the Company believes shareholders should support the Company's three nominees for the Board of Directors (the "Board") at the 2018 annual meeting of shareholders that will take place on June 17, 2019.

  • PR Newswire

    MiMedx Shareholders Should Visit www.VoteBlueForMiMedx.com

    MARIETTA, Ga., June 4, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today encouraged shareholders to visit its new campaign website, www.VoteBlueForMiMedx.com. MiMedx launched the website in connection with the upcoming 2018 annual meeting of shareholders ("Annual Meeting"). An overview of the comprehensive board refreshment plan announced on May 30, 2019 and the highly qualified and experienced MiMedx nominees who are up for election at the Annual Meeting.

  • PR Newswire

    MiMedx Files Definitive Proxy Materials and Mails Letter to Shareholders

    MARIETTA, Ga., June 3, 2019 /PRNewswire/ -- MiMedx Group, Inc. (OTC PINK: MDXG) ("MiMedx" or the "Company"), an industry leader in advanced wound care and an emerging therapeutic biologics company, today announced that it has filed definitive proxy materials with the U.S. Securities and Exchange Commission ("SEC") in connection with its upcoming 2018 annual meeting of shareholders ("Annual Meeting") scheduled to be held on June 17, 2019 at 9:00 a.m. local time, at the Marietta Conference Center (Hilton Atlanta/Marietta) at 500 Powder Springs St., Marietta, GA 30064. The Company has nominated to the board of directors of the Company (the "Board") three experienced healthcare professionals, none of whom has served on the MiMedx Board previously. Two of these candidates were identified by one of the Company's largest shareholders, Prescience Point Capital Management LLC (together with its affiliates, "Prescience Point"), and the third candidate is our new Chief Executive Officer.

  • Here's Why Shares of MiMedx Group Jumped Higher Today
    Motley Fool

    Here's Why Shares of MiMedx Group Jumped Higher Today

    A new board could signify the start of a turnaround.